Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2000
07/06/2000WO2000039111A1 Antithrombotic amides
07/06/2000WO2000039108A1 Thrombin or factor xa inhibitors
07/06/2000WO2000039106A1 Acrylonitrile compounds
07/06/2000WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000039101A1 Pyrimidine compounds
07/06/2000WO2000039097A1 Imidazole compounds and medicinal use thereof
07/06/2000WO2000039094A1 Substituted pyridine herbicides
07/06/2000WO2000039092A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa
07/06/2000WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
07/06/2000WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands
07/06/2000WO2000039088A1 Glucagon antagonists/inverse agonists
07/06/2000WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
07/06/2000WO2000039083A2 Pyrazole compounds and uses thereof
07/06/2000WO2000039082A2 1,2-annelated quinoline derivatives
07/06/2000WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/06/2000WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
07/06/2000WO2000038720A1 Remedies for pain
07/06/2000WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
07/06/2000WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
07/06/2000WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000038685A1 Solution phase synthesis of compounds including amine alcohol functionality
07/06/2000WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000038680A1 Azabicycloalkanes as ccr5 modulators
07/06/2000WO2000038677A1 Indole and indolizidine derivatives for the treatment of migraine
07/06/2000WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000WO2000038618A2 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
07/06/2000WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2361149A1 Aromatic amides
07/06/2000CA2358095A1 Heteroroaromatic amides as inhibitor of factor xa
07/06/2000CA2358091A1 Antithrombotic amides
07/06/2000CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds
07/06/2000CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia
07/06/2000CA2356838A1 Imidazole compounds and medicinal use thereof
07/06/2000CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2356638A1 Indole and indolizidine derivatives for the treatment of migraine
07/06/2000CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000CA2356269A1 Pain control agent
07/06/2000CA2356214A1 Heterocyclic amides as inhibitors of factor xa
07/06/2000CA2356141A1 Acrylonitrile compounds
07/06/2000CA2355744A1 Novel inhibitors of farnesyl-protein transferase
07/06/2000CA2352896A1 Pyrimidine compounds
07/06/2000CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
07/06/2000CA2349557A1 Thrombin or factor xa inhibitors
07/06/2000CA2348740A1 Thrombin or factor xa inhibitors
07/06/2000CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production
07/06/2000CA2320730A1 Thrombin or factor xa inhibitors
07/05/2000EP1016661A1 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
07/05/2000EP1015449A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors
07/05/2000EP1015445A1 Antimicrobial quinolones, their compositions and uses
07/05/2000EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof
07/05/2000EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2
07/05/2000EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
07/05/2000EP1014988A2 Treatment of hepatic cirrhosis
07/05/2000EP1014976A1 Novel substituted imidazole compounds
07/05/2000EP1014974A1 Treatment of schizophrenia and psychosis
07/05/2000EP1014962A1 Antithrombotic agents
07/05/2000EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives
07/05/2000EP0831923A4 Separation of active complexes
07/05/2000EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/05/2000EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
07/05/2000EP0637241B1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
07/05/2000EP0630367B1 Novel arylindazoles and their use as herbicides
07/05/2000CN1259126A Pharmacological agents
07/05/2000CN1259125A Substituted 3-cyano quinolines
07/05/2000CN1259049A Carboxamides useful as 5-HT1F agonists
07/05/2000CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component
07/05/2000CN1258672A Amino-compound
07/05/2000CN1054124C Aminoquinoline derivatives and its application of salt
07/05/2000CN1054123C Process for producing carbamic acid derivatives
07/04/2000US6084130 For treatment of central nervous system disorders
07/04/2000US6084105 Cyclization in the presence of a base a 2-arylhydrazino-succinonitrile compound to produce a 5-amino-1-aryl-3-cyano-pyrazole pesticide intermediate
07/04/2000US6084100 Reacting 8-chloro-5,6-dihydrobenzo(5,6)cyclohepta(1,2-b)-pyridin-11-one and ethyl 4-oxopiperidine-1-carboxylate in an organic solvent in the presence of a tertiary amine with a low-valent titanium compound; cross reductive coupling
07/04/2000US6084098 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
07/04/2000US6083961 For prevention and/or treatment of bradykinin or its analogues mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain
07/04/2000US6083960 Constrained somatostatin agonists and antagonists
07/04/2000US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments
07/04/2000US6083958 Anti-HIV composition containing imidazole derivative
07/04/2000US6083955 Having a high affinity for drugs, especially endoserine receptors
07/04/2000US6083950 Treatment of peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy
07/04/2000US6083949 For treating cancer in which raf kinase is implicated, as well as compounds which inhibit, suppress or antagonize the production or activity of cytokines such as interleukins and tumor necrosis factor
07/04/2000US6083944 Enzyme inhibitors; treatment of various debilitating disorders
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
06/2000
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037460A1 5-azolylpyrimidine compounds, process for the preparation of the same, and germicides for agricultural and horticultural use
06/29/2000WO2000037459A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000WO2000037458A1 Farnesyl protein transferase inhibitors
06/29/2000WO2000037457A1 Process for preparing tricyclic compounds having antihistaminic activity
06/29/2000WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives
1 ... 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 ... 1080